Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,862,069
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
23,399,373
-
Shares change
-
-934,498
-
Total reported value, excl. options
-
$399,913,116
-
Value change
-
-$7,528,050
-
Number of buys
-
22
-
Number of sells
-
-29
-
Price
-
$17.09
Significant Holders of HilleVax, Inc. - Common Stock (HLVX) as of Q3 2022
64 filings reported holding HLVX - HilleVax, Inc. - Common Stock as of Q3 2022.
HilleVax, Inc. - Common Stock (HLVX) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,399,373 shares
of 49,862,069 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9,758,359 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,653,231 shares), Abingworth LLP (1,838,486 shares), RA CAPITAL MANAGEMENT, L.P. (1,760,019 shares), T. Rowe Price Investment Management, Inc. (1,100,000 shares), BlackRock Inc. (772,054 shares), PERCEPTIVE ADVISORS LLC (764,907 shares), StepStone Group LP (676,567 shares), FRANKLIN RESOURCES INC (673,031 shares), and VANGUARD GROUP INC (629,754 shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.